Allegheny Financial Group
Source: SEC Form 13F · as of Mar 2026Allegheny Financial Group holds 20 biotech & pharma companies tracked by BioSniper, totaling $24.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$24.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 7,997 | $7.4M |
| MRKMerck & Co., Inc. | 29,711 | $3.6M |
| JNJJOHNSON & JOHNSON | 10,537 | $2.6M |
| PMPhilip Morris International Inc | 13,805 | $2.3M |
| ABBVAbbVie Inc. | 8,715 | $1.9M |
| PFEPFIZER INC | 45,347 | $1.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,018 | $901K |
| ABTABBOTT LABORATORIES | 7,218 | $741K |
| AMGNAMGEN INC | 1,836 | $646K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,109 | $571K |
| BMYBRISTOL MYERS SQUIBB CO | 8,694 | $527K |
| CAHCardinal Health Inc. | 2,083 | $440K |
| MCKMcKesson Corporation | 391 | $338K |
| DGXQuest Diagnostics Incorporated | 1,597 | $313K |
| BIIBBIOGEN INC. | 1,450 | $266K |
| INSMINSMED Inc | 1,479 | $242K |
| ANNXAnnexon, Inc. | 42,900 | $238K |
| PGENPRECIGEN, INC. | 17,065 | $66K |
| TSHATaysha Gene Therapies, Inc. | 12,000 | $54K |
| LCTXLineage Cell Therapeutics, Inc. | 20,000 | $32K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.